Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
11.06
0.10 (0.91%)
At close: Aug 15, 2025, 12:19 PM

Avanos Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-392.1M -61.8M 50.5M 5.2M
Depreciation & Amortization
45.5M 46.1M 47.7M 38.3M
Stock-Based Compensation
13.8M 15.8M 15.9M 13.2M
Other Working Capital
3.5M -47.3M -4.1M 31.5M
Other Non-Cash Items
398.5M 50.3M 1.1M 8M
Deferred Income Tax
n/a n/a n/a -3.4M
Change in Working Capital
35.9M -18M -24.3M 26M
Operating Cash Flow
100.7M 32.4M 90.9M 87.3M
Capital Expenditures
-17.8M -17.8M -19.3M -21M
Cash Acquisitions
n/a 39.4M -116.1M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-9.7M n/a -116.1M n/a
Investing Cash Flow
-27.5M 21.6M -135.4M -21M
Debt Repayment
-33.6M -64.7M 103.4M -50M
Common Stock Repurchased
-12.8M -19.1M -45.5M -11.5M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.7M -10.4M -1.2M 6.2M
Financial Cash Flow
-49.1M -94.2M 56.7M -55.3M
Net Cash Flow
20M -40M 9.2M 7M
Free Cash Flow
82.9M 14.6M 71.6M 66.3M